Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia

Clinical Infectious Diseases

Volumn 47, Issue 12, 2008, Pages 1571-1574

  Chalmers, James D ^a   Singanayagam, Aran ^a   Hill, Adam T ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; INOTROPIC AGENT; UREA;

ADULT; AGE; ARTERIAL PH; ARTICLE; ARTIFICIAL VENTILATION; BREATHING RATE; COMMUNITY ACQUIRED PNEUMONIA; CONFUSION; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; OXYGENATION; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; THORAX RADIOGRAPHY;

CARDIOTONIC AGENTS; COMMUNITY-ACQUIRED INFECTIONS; GREAT BRITAIN; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA, BACTERIAL; RESPIRATION, ARTIFICIAL; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 56749166149     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/593195     Document Type: Article

References (10)

1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Disease Society of America/American Thoracic Society consensus guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44:S27-72.
2. Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 2005; 118:384-92.
3. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58:377-82.
4. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low risk patients with community acquired pneumonia. N Engl J Med 1997; 336:243-50.
5. Buising KL, Thursky KA, Black JF, et al. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax 2006; 61:419-24.
6. Simpson JC, MacFarlane JT, Watson J, Woodhead MA. A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales. Thorax 2000; 55:1040-5.
7. Lim WS, MacFarlane JT. Defining prognostic factors in the elderly with community acquired pneumonia: a case controlled study of patients aged ≥75 yrs. Eur Respir J 2001; 17:200-5.
8. McCartney C, Cookson B, Dance D, et al. Interim guidance on diagnosis and management of Panton-Valentine-leukocidin-associated staphylococcal infections in the UK. London: Department of Health, 2006.
9. Chalmers JD, Singanayagam A, Hill AT. Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia. Thorax 2008; 63:698-702.
10. Charles PG, Wolfe R, Whitby M, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008; 47:375-84.